Lai Kwok Leung
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Lai Kwok Leung has a total of 131 co-authors. Here are the top co-authors by number of shared publications:
- Franky Leung Chan
School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong, China
13 shared publications - Yan Qin Tan
Programme of Food Science and Technology, Department of Life Sciences, Beijing Normal-Hong Kong Baptist University, Zhuhai, Guangdong 519087, China; Guangdong Provincial/Zhuhai Key Laboratory of IRADS, Beijing Normal-Hong Kong Baptist University, Zhuhai, Guangdong 519087, China
12 shared publications Tsz Yan Wong
Food and Nutritional Sciences Programme, School of Life Sciences, Faculty of Science, The Chinese University of Hong Kong, Shatin, Hong Kong
11 shared publicationsZhen-Yu Chen
Department of Biochemistry, Faculty of Medicine, The Chinese University of Hong Kong, Room 507C, MMW Bldg, Shatin NT, Hong Kong
10 shared publicationsShu-Mei Lin
Department of Food Science, National Chiayi University, Chiayi City, Taiwan
9 shared publications- Yu Huang
Department of Biomedical Sciences, City University of Hong Kong, Hong Kong, China
9 shared publications
Latest Publications
- Open Access
- 27 February 2025
- Published by Wiley in Cancer Medicine
- Vol. 14 (5) , e70705
Licorice Extract Isoliquiritigenin Increased Cytosol Calcium and Induced Apoptosis in Colon Cancer Cells via Transient Receptor Potential Vanilloid‐1
Background: Colorectal cancer (CRC) is the third most common malignant tumor, and the fifth cause of cancer‐related death in China, while chemotherapy is the primary strategy for CRC. Transient receptor potential (TRP) channels are non‐selective cation channels while modulating the expression or activity of TRP channels results in the regulation of Ca2+ influx. Previous studies have shown that TRP members with altered expression or channel activity are presented in CRC cells, which made them become promising therapeutic targets. Isoliquiritigenin (ISL), one of the major bioactive ingredients from traditional Chinese medicine licorice, was reported to exhibit anti‐cancer properties such as induce apoptosis in CRC cells, but the underlying mechanism was not fully understood, whether its anticancer activity was related to regulating intracellular calcium and TRP channels remains for further investigation.Objective: The study aims to investigate the effect of ISL on altering cytosol calcium in CRC cells and elucidate its potential molecular mechanism.Methods: The study was conducted on 2 CRC cell lines HT29 and HCT116. Changes of cytosol calcium was indicated by live cell Ca2+ imaging. Expression level of TRPV1 was determined by western blot. Cell apoptosis was detected by flow cytometry with Annexin V‐FITC/PI staining.Results: ISL significantly increased cytosol calcium in HT29 and HCT116 cells. The ISL‐induced increasing calcium ions were from both calcium influx and intracellular calcium release. ISL co‐culture directly upregulated the expression of transient receptor potential vanilloid‐1 (TRPV1) in colon cancer cells. Inhibition of TRPV1 by capsazepine (CapZ) abrogated the ISL‐induced calcium influx and ISL‐induced apoptosis in HT29 and HCT116 cells.Conclusions: This study illustrates, for the first time, that ISL increased cytosol calcium concentration and induced apoptosis via TRPV1 in colon cancer cells, giving a new understanding of the underlying mechanism of its anti‐cancer ability and making it a potential regulator for TRPV1.
- 27 February 2025
- Published by Wiley in Cancer Medicine
- Vol. 14 (5) , e70705
Open AccessLicorice Extract Isoliquiritigenin Increased Cytosol Calcium and Induced Apoptosis in Colon Cancer Cells via Transient Receptor Potential Vanilloid‐1
Background: Colorectal cancer (CRC) is the third most common malignant tumor, and the fifth cause of cancer‐related death in China, while chemotherapy is the primary strategy for CRC. Transient receptor potential (TRP) channels are non‐selective cation channels while modulating the expression or activity of TRP channels results in the regulation of Ca2+ influx. Previous studies have shown that TRP members with altered expression or channel activity are presented in CRC cells, which made them become promising therapeutic targets. Isoliquiritigenin (ISL), one of the major bioactive ingredients from traditional Chinese medicine licorice, was reported to exhibit anti‐cancer properties such as induce apoptosis in CRC cells, but the underlying mechanism was not fully understood, whether its anticancer activity was related to regulating intracellular calcium and TRP channels remains for further investigation.Objective: The study aims to investigate the effect of ISL on altering cytosol calcium in CRC cells and elucidate its potential molecular mechanism.Methods: The study was conducted on 2 CRC cell lines HT29 and HCT116. Changes of cytosol calcium was indicated by live cell Ca2+ imaging. Expression level of TRPV1 was determined by western blot. Cell apoptosis was detected by flow cytometry with Annexin V‐FITC/PI staining.Results: ISL significantly increased cytosol calcium in HT29 and HCT116 cells. The ISL‐induced increasing calcium ions were from both calcium influx and intracellular calcium release. ISL co‐culture directly upregulated the expression of transient receptor potential vanilloid‐1 (TRPV1) in colon cancer cells. Inhibition of TRPV1 by capsazepine (CapZ) abrogated the ISL‐induced calcium influx and ISL‐induced apoptosis in HT29 and HCT116 cells.Conclusions: This study illustrates, for the first time, that ISL increased cytosol calcium concentration and induced apoptosis via TRPV1 in colon cancer cells, giving a new understanding of the underlying mechanism of its anti‐cancer ability and making it a potential regulator for TRPV1.
- Open Access
- 27 September 2024
- Published by Springer Nature in Cancer Cell International
- Vol. 24 (1) , 1-19
TRPV2 calcium channel promotes breast cancer progression potential by activating autophagy
Breast cancer, the most prevalent and aggressive tumor affecting women, requires identification of disease determinants to facilitate the development of effective therapeutic strategies. Transient receptor potential vanilloid 2 (TRPV2), an ion channel highly permeable for calcium (Ca2+), is implicated in physiological and pathological processes. Nevertheless, the role of TRPV2 in breast cancer remains poorly elucidated. In this study, we found high levels of TRPV2 expression associated with advanced malignancy, thereby suggesting its potential as a biomarker for breast cancer staging. We demonstrated that TRPV2 activation promotes breast cancer cell proliferation, migration, and invasion, while silencing of TRPV2 suppresses breast cancer progression, highlighting the oncogenic role of TRPV2. Moreover, we reveal that TRPV2 facilitates cancer progression by modulating the CaMKKβ/AMPK/ULK1-autophagic axis through mediating calcium influx, providing new insights into TRPV2 as a novel therapeutic target for breast cancer treatment.
- 27 September 2024
- Published by Springer Nature in Cancer Cell International
- Vol. 24 (1) , 1-19
Open AccessTRPV2 calcium channel promotes breast cancer progression potential by activating autophagy
Breast cancer, the most prevalent and aggressive tumor affecting women, requires identification of disease determinants to facilitate the development of effective therapeutic strategies. Transient receptor potential vanilloid 2 (TRPV2), an ion channel highly permeable for calcium (Ca2+), is implicated in physiological and pathological processes. Nevertheless, the role of TRPV2 in breast cancer remains poorly elucidated. In this study, we found high levels of TRPV2 expression associated with advanced malignancy, thereby suggesting its potential as a biomarker for breast cancer staging. We demonstrated that TRPV2 activation promotes breast cancer cell proliferation, migration, and invasion, while silencing of TRPV2 suppresses breast cancer progression, highlighting the oncogenic role of TRPV2. Moreover, we reveal that TRPV2 facilitates cancer progression by modulating the CaMKKβ/AMPK/ULK1-autophagic axis through mediating calcium influx, providing new insights into TRPV2 as a novel therapeutic target for breast cancer treatment.
- 1 June 2021
- Published by Elsevier in Toxicology Letters
- Vol. 344, 18-25
The mycoestrogen zeranol at high dosage antagonizes transient receptor potential channel activities in 3T3 L1 cells
- 1 June 2021
- Published by Elsevier in Toxicology Letters
- Vol. 344, 18-25
The mycoestrogen zeranol at high dosage antagonizes transient receptor potential channel activities in 3T3 L1 cells
- 1 August 2020
- Published by Elsevier in Chemosphere
- Vol. 253, 126772
The livestock growth-promoter zeranol facilitates GLUT4 translocation in 3T3 L1 adipocytes
- 1 August 2020
- Published by Elsevier in Chemosphere
- Vol. 253, 126772
The livestock growth-promoter zeranol facilitates GLUT4 translocation in 3T3 L1 adipocytes
- 27 June 2019
- Published by Springer Nature in Oncogene
- Vol. 38 (29) , 5778-5791
Knockdown of TM9SF4 boosts ER stress to trigger cell death of chemoresistant breast cancer cells
Drug resistance is one of the major obstacles to breast cancer therapy. However, the mechanisms of how cancer cells develop chemoresistance are still not fully understood. In the present study, we found that expression of TM9SF4 proteins was much higher in adriamycin (ADM)-resistant breast cancer cells MCF-7/ADM than in its parental line wild-type breast cancer cells MCF-7/WT. shRNA-mediated knockdown of TM9SF4 preferentially reduced cell growth and triggered cell death in chemoresistant MCF-7/ADM cells compared with MCF-7/WT cells. Knockdown of TM9SF4 also reduced cell growth and triggered cell death in chemoresistant MDA-MB-231/GEM cells. Mechanistic studies showed that TM9SF4 knockdown increased protein misfolding and elevated endoplasmic reticulum (ER) stress level in MCF-7/ADM cells, as indicated by aggresome formation and upregulated expression of ER stress markers, the effect of which was reversed by a small molecule chaperone 4-phenybutyric acid. In an athymic nude mouse model of ADM-resistant human breast xenograft tumor, knockdown of TM9SF4 decreased the growth of tumor xenografts. In chemoresistant breast cancer patients, chemotherapy increased the expression of TM9SF4 proteins in breast tumor samples. Taken together, these results uncovered a novel role of TM9SF4 proteins in alleviating ER stress and protecting chemoresistant breast cancer cells from apoptotic/necrotic cell death. These results highlight a possible strategy of targeting TM9SF4 to overcome breast cancer chemoresistance.
- 27 June 2019
- Published by Springer Nature in Oncogene
- Vol. 38 (29) , 5778-5791
Knockdown of TM9SF4 boosts ER stress to trigger cell death of chemoresistant breast cancer cells
Drug resistance is one of the major obstacles to breast cancer therapy. However, the mechanisms of how cancer cells develop chemoresistance are still not fully understood. In the present study, we found that expression of TM9SF4 proteins was much higher in adriamycin (ADM)-resistant breast cancer cells MCF-7/ADM than in its parental line wild-type breast cancer cells MCF-7/WT. shRNA-mediated knockdown of TM9SF4 preferentially reduced cell growth and triggered cell death in chemoresistant MCF-7/ADM cells compared with MCF-7/WT cells. Knockdown of TM9SF4 also reduced cell growth and triggered cell death in chemoresistant MDA-MB-231/GEM cells. Mechanistic studies showed that TM9SF4 knockdown increased protein misfolding and elevated endoplasmic reticulum (ER) stress level in MCF-7/ADM cells, as indicated by aggresome formation and upregulated expression of ER stress markers, the effect of which was reversed by a small molecule chaperone 4-phenybutyric acid. In an athymic nude mouse model of ADM-resistant human breast xenograft tumor, knockdown of TM9SF4 decreased the growth of tumor xenografts. In chemoresistant breast cancer patients, chemotherapy increased the expression of TM9SF4 proteins in breast tumor samples. Taken together, these results uncovered a novel role of TM9SF4 proteins in alleviating ER stress and protecting chemoresistant breast cancer cells from apoptotic/necrotic cell death. These results highlight a possible strategy of targeting TM9SF4 to overcome breast cancer chemoresistance.
- Open Access
- 20 February 2019
- Published by Wiley in The FASEB Journal
- Vol. 33 (5) , 6526-6538
The activity of transient receptor potential channel C‐6 modulates the differentiation of fat cells
Previously, the V1‐3 isoforms of the transient receptor potential channel (TRP) have been shown to promote or prevent adipocyte differentiation. In the current study, the C isoforms were screened for blocking adipogenesis. The hypothesis that the TRP classic or canonical (TRPC) deters adipocyte differentiation was investigated in 3T3‐L1 cells employing the channel‐specific activator and antagonist, silencing, and overexpression techniques. Fat accumulation in cells was visualized by Oil Red O staining. Intracellular calcium inflow was estimated by confocal microscopy. A high‐fat (HF) feeding study was also performed on C57BL/6J mice to verify the findings in the cell model. Among the 6 C isoforms tested, only TRPC‐6 inhibited the differentiation of fat cells. The phytochemical quercetin induced the channel protein expression. Calcium‐imaging results also revealed that the flavonoid could trigger calcium inflow. Coadministration of quercetin (1 or 20 mg/kg body weight) in an HF diet prevented TRPC‐6 from declining and attenuated phosphorylated (p)‐PKB and PI3k, as well as the proliferation of visceral fat cells. The present study illustrated that TRPC‐6 activation could perturb adipocyte differentiation. The food f lavonoid quercetin was a TRPC‐6 inducer and activator and it could prevent adipogenesis in mice.—Tan, Y. Q., Kwan, H. Y., Yao, X., Leung, L. K. The activity of transient receptor potential channel C‐6 modulates the differentiation of fat cells. FASEB J. 33, 6526–6538 (2019). www.fasebj.org
- 20 February 2019
- Published by Wiley in The FASEB Journal
- Vol. 33 (5) , 6526-6538
Open AccessThe activity of transient receptor potential channel C‐6 modulates the differentiation of fat cells
Previously, the V1‐3 isoforms of the transient receptor potential channel (TRP) have been shown to promote or prevent adipocyte differentiation. In the current study, the C isoforms were screened for blocking adipogenesis. The hypothesis that the TRP classic or canonical (TRPC) deters adipocyte differentiation was investigated in 3T3‐L1 cells employing the channel‐specific activator and antagonist, silencing, and overexpression techniques. Fat accumulation in cells was visualized by Oil Red O staining. Intracellular calcium inflow was estimated by confocal microscopy. A high‐fat (HF) feeding study was also performed on C57BL/6J mice to verify the findings in the cell model. Among the 6 C isoforms tested, only TRPC‐6 inhibited the differentiation of fat cells. The phytochemical quercetin induced the channel protein expression. Calcium‐imaging results also revealed that the flavonoid could trigger calcium inflow. Coadministration of quercetin (1 or 20 mg/kg body weight) in an HF diet prevented TRPC‐6 from declining and attenuated phosphorylated (p)‐PKB and PI3k, as well as the proliferation of visceral fat cells. The present study illustrated that TRPC‐6 activation could perturb adipocyte differentiation. The food f lavonoid quercetin was a TRPC‐6 inducer and activator and it could prevent adipogenesis in mice.—Tan, Y. Q., Kwan, H. Y., Yao, X., Leung, L. K. The activity of transient receptor potential channel C‐6 modulates the differentiation of fat cells. FASEB J. 33, 6526–6538 (2019). www.fasebj.org
- 1 August 2018
- Published by Elsevier in Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology
- Vol. 210, 57-64
The citrus flavonone hesperetin attenuates the nuclear translocation of aryl hydrocarbon receptor
- 1 August 2018
- Published by Elsevier in Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology
- Vol. 210, 57-64
The citrus flavonone hesperetin attenuates the nuclear translocation of aryl hydrocarbon receptor
- Open Access
- 3 July 2018
- Published by Impact Journals, LLC in Oncotarget
- Vol. 9 (51) , 29619-29633
PCP4/PEP19 upregulates aromatase gene expression via CYP19A1 promoter I.1 in human breast cancer SK-BR-3 cells
Oncotarget | https://doi.org/10.18632/oncotarget.25651 Kie Honjo, Taiji Hamada, Takuya Yoshimura, Seiya Yokoyama, Sohsuke Yamada, Yan-Qin Tan, Lai K. Leung, Norifumi Nakamura, Yasuyo Ohi, Michiyo Higashi, Akihide... PCP4/PEP19 upregulates aromatase gene expression via CYP19A1 promoter I.1 in human breast cancer SK-BR-3 cells
- 3 July 2018
- Published by Impact Journals, LLC in Oncotarget
- Vol. 9 (51) , 29619-29633
Open AccessPCP4/PEP19 upregulates aromatase gene expression via CYP19A1 promoter I.1 in human breast cancer SK-BR-3 cells
Oncotarget | https://doi.org/10.18632/oncotarget.25651 Kie Honjo, Taiji Hamada, Takuya Yoshimura, Seiya Yokoyama, Sohsuke Yamada, Yan-Qin Tan, Lai K. Leung, Norifumi Nakamura, Yasuyo Ohi, Michiyo Higashi, Akihide... PCP4/PEP19 upregulates aromatase gene expression via CYP19A1 promoter I.1 in human breast cancer SK-BR-3 cells
- 25 June 2018
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 70 (9) , 1253-1261
Co-administrating apigenin in a high-cholesterol diet prevents hypercholesterolaemia in golden hamsters
Objectives Hypercholesterolaemia is a major risk factor for developing atherosclerosis. Increased consumption of fruits and vegetables is recommended to hypercholesterolaemic patients. In this study, the hypocholesterolaemic effect of apigenin and luteolin was evaluated in a hamster model. Methods Hamsters were put on a high‐cholesterol diet for 9 weeks, and apigenin or luteolin was administered in the diet at 60 and 300 ppm. Key findings Both apigenin and luteolin supplementations could attenuate the aorta plaque formation by 30% and 20%, respectively. Apigenin‐fed hamsters at both dosages displayed a 1.5‐fold increase in hepatic Ldlr expression and a 40% reduction in non‐HDL cholesterol level as compared with those in the control fed a high‐cholesterol (HC) diet. Besides, faecal elimination of cholesterol was facilitated by 20% in the hamsters with high apigenin consumption. Suppressing the expression of the cholesterol transporter ncp1l1 in the intestinal mucosa could block the cholesterol absorption and promote its elimination. The differential regulations of ncp1l1 and Ldlr appeared to be the underlying hypocholesterolaemic mechanism of apigenin in this model system. Luteolin supplementation, on the other hand, had no effect on the blood cholesterol. Conclusions This study illustrated that dietary administration of apigenin attenuated HC feeding‐induced hypercholesterolemia in hamsters.
- 25 June 2018
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 70 (9) , 1253-1261
Co-administrating apigenin in a high-cholesterol diet prevents hypercholesterolaemia in golden hamsters
Objectives Hypercholesterolaemia is a major risk factor for developing atherosclerosis. Increased consumption of fruits and vegetables is recommended to hypercholesterolaemic patients. In this study, the hypocholesterolaemic effect of apigenin and luteolin was evaluated in a hamster model. Methods Hamsters were put on a high‐cholesterol diet for 9 weeks, and apigenin or luteolin was administered in the diet at 60 and 300 ppm. Key findings Both apigenin and luteolin supplementations could attenuate the aorta plaque formation by 30% and 20%, respectively. Apigenin‐fed hamsters at both dosages displayed a 1.5‐fold increase in hepatic Ldlr expression and a 40% reduction in non‐HDL cholesterol level as compared with those in the control fed a high‐cholesterol (HC) diet. Besides, faecal elimination of cholesterol was facilitated by 20% in the hamsters with high apigenin consumption. Suppressing the expression of the cholesterol transporter ncp1l1 in the intestinal mucosa could block the cholesterol absorption and promote its elimination. The differential regulations of ncp1l1 and Ldlr appeared to be the underlying hypocholesterolaemic mechanism of apigenin in this model system. Luteolin supplementation, on the other hand, had no effect on the blood cholesterol. Conclusions This study illustrated that dietary administration of apigenin attenuated HC feeding‐induced hypercholesterolemia in hamsters.
- 1 December 2017
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 96, 1000-1007
Apigenin and luteolin display differential hypocholesterolemic mechanisms in mice fed a high-fat diet
- 1 December 2017
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 96, 1000-1007
Apigenin and luteolin display differential hypocholesterolemic mechanisms in mice fed a high-fat diet